Argus
•
Oct 21, 2026
RGEN: Raising target price to $188.00
Summary
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Alnylam Pharmaceuticals, Inc.
Oct 30, 2026
•
ALNY
Daily – Vickers Top Buyers & Sellers for 10/30/2026
Oct 30, 2026
•
TFC, IBKR, ENVA, DINO, HBAN, TRV, XYL, PNFP, DHR
Analyst Report: Thermo Fisher Scientific Inc
Oct 30, 2026
•
TMO
Market Digest: AMZN, TT, KLAC, LLY, LMT, MSFT, PSA, TMO, MA, AGNC, HLT, STRL
Oct 30, 2026
•
TT, KLAC, MSFT, HLT, LMT, MA, AGNC, TMO, LLY, STRL, AMZN, PSA
Analyst Report: Merck & Co., Inc.
Oct 29, 2026
•
MRK
